ROCHE/CORANGE MERGER CLEARED IN EUROPE WITHOUT PHARMACEUTICAL DIVESTITURES; DIAGNOSTIC SALE, EXPANDED PCR LICENSING ARE CONDITIONS OF EU CLEARANCE
Executive Summary
The acquisition of Corange by Roche may proceed in Europe with no pharmaceutical-related divestitures, the European Commission announced Feb. 4.